Evoq Remedies Limited (BOM:543500)
2.880
-0.100 (-3.36%)
At close: Jan 22, 2026
Evoq Remedies Revenue
Evoq Remedies had revenue of 265.68M INR in the half year ending September 30, 2025, with 580.78% growth. This brings the company's revenue in the last twelve months to 407.29M, up 1,585.10% year-over-year. In the fiscal year ending March 31, 2025, Evoq Remedies had annual revenue of 141.71M with 124.62% growth.
Revenue (ttm)
407.29M
Revenue Growth
+1,585.10%
P/S Ratio
0.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
71.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 141.71M | 78.62M | 124.62% |
| Mar 31, 2024 | 63.09M | -201.04M | -76.11% |
| Mar 31, 2023 | 264.13M | 96.29M | 57.38% |
| Mar 31, 2022 | 167.83M | 67.58M | 67.42% |
| Mar 31, 2021 | 100.25M | 9.53M | 10.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.25T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| HDFC Bank | 2.85T |
| Larsen & Toubro | 2.76T |
| Tata Consultancy Services | 2.61T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |